These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 16485159

  • 1. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
    Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard AC, Isaac S, Gilly FN, Glehen O.
    Ann Surg Oncol; 2006 Mar; 13(3):405-12. PubMed ID: 16485159
    [Abstract] [Full Text] [Related]

  • 2. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
    Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S.
    J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
    [Abstract] [Full Text] [Related]

  • 3. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M.
    Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
    [Abstract] [Full Text] [Related]

  • 4. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M.
    Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
    [Abstract] [Full Text] [Related]

  • 5. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.
    Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
    Chua TC, Yan TD, Morris DL.
    J Surg Oncol; 2009 Feb 01; 99(2):109-13. PubMed ID: 19016259
    [Abstract] [Full Text] [Related]

  • 7. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Baratti D, Vaira M, Kusamura S, D'Amico S, Balestra MR, Cioppa T, Mingrone E, De Simone M, Deraco M.
    Eur J Surg Oncol; 2010 Nov 01; 36(11):1047-53. PubMed ID: 20832234
    [Abstract] [Full Text] [Related]

  • 8. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.
    In Vivo; 2009 Nov 01; 23(4):639-44. PubMed ID: 19567401
    [Abstract] [Full Text] [Related]

  • 9. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
    Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras Ad AD, Kusamura S.
    Ann Surg Oncol; 2006 Feb 01; 13(2):229-37. PubMed ID: 16444562
    [Abstract] [Full Text] [Related]

  • 10. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.
    Ann Surg Oncol; 2008 Feb 01; 15(2):526-34. PubMed ID: 18043976
    [Abstract] [Full Text] [Related]

  • 11. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin.
    Glehen O, Cotte E, Schreiber V, Sayag-Beaujard AC, Vignal J, Gilly FN.
    Br J Surg; 2004 Jun 01; 91(6):747-54. PubMed ID: 15164446
    [Abstract] [Full Text] [Related]

  • 12. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.
    Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH.
    J Clin Oncol; 2009 Dec 20; 27(36):6237-42. PubMed ID: 19917862
    [Abstract] [Full Text] [Related]

  • 13. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
    Yano H, Moran BJ, Cecil TD, Murphy EM.
    Eur J Surg Oncol; 2009 Sep 20; 35(9):980-5. PubMed ID: 18977109
    [Abstract] [Full Text] [Related]

  • 14. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A, Naticchioni E, Biacchi D, Sibio S, Accarpio F, Rocco M, Tarquini S, Di Seri M, Ciardi A, Montruccoli D, Sammartino P.
    Cancer; 2008 Jul 15; 113(2):315-25. PubMed ID: 18473354
    [Abstract] [Full Text] [Related]

  • 15. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
    Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, Gilly F, Glehen O.
    Dis Colon Rectum; 2005 Jul 15; 48(7):1372-9. PubMed ID: 15909071
    [Abstract] [Full Text] [Related]

  • 16. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
    Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M.
    Cancer; 2006 Mar 01; 106(5):1144-53. PubMed ID: 16456817
    [Abstract] [Full Text] [Related]

  • 17. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH.
    Eur J Surg Oncol; 2001 Apr 01; 27(3):239-43. PubMed ID: 11373099
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A, Borzellino G, Momo EN, Segattini C, Pitoni F, Steccanella F, De Manzoni G.
    Ann Ital Chir; 2008 Apr 01; 79(4):231-9. PubMed ID: 19093624
    [Abstract] [Full Text] [Related]

  • 19. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
    Feldman AL, Libutti SK, Pingpank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, Steinberg SM, Liewehr DJ, Kleiner DE, Alexander HR.
    J Clin Oncol; 2003 Dec 15; 21(24):4560-7. PubMed ID: 14673042
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.